Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs KILITCH DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA KILITCH DRUGS ASTRAZENECA PHARMA/
KILITCH DRUGS
 
P/E (TTM) x 95.5 49.0 194.9% View Chart
P/BV x 22.7 4.3 529.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ASTRAZENECA PHARMA   KILITCH DRUGS
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
KILITCH DRUGS
Mar-23
ASTRAZENECA PHARMA/
KILITCH DRUGS
5-Yr Chart
Click to enlarge
High Rs3,620218 1,658.1%   
Low Rs2,438121 2,009.7%   
Sales per share (Unadj.) Rs401.289.6 447.7%  
Earnings per share (Unadj.) Rs39.75.3 747.0%  
Cash flow per share (Unadj.) Rs46.27.6 608.6%  
Dividends per share (Unadj.) Rs16.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs234.493.9 249.8%  
Shares outstanding (eoy) m25.0015.58 160.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.51.9 398.3%   
Avg P/E ratio x76.331.9 238.7%  
P/CF ratio (eoy) x65.522.4 293.1%  
Price / Book Value ratio x12.91.8 714.0%  
Dividend payout %40.30-   
Avg Mkt Cap Rs m75,7182,646 2,861.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,591117 2,208.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,0301,396 718.5%  
Other income Rs m26129 894.4%   
Total revenues Rs m10,2911,425 722.1%   
Gross profit Rs m1,249177 704.4%  
Depreciation Rs m16336 457.9%   
Interest Rs m651 12.4%   
Profit before tax Rs m1,341120 1,116.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34837 932.7%   
Profit after tax Rs m99383 1,198.7%  
Gross profit margin %12.512.7 98.0%  
Effective tax rate %26.031.1 83.6%   
Net profit margin %9.95.9 166.9%  
BALANCE SHEET DATA
Current assets Rs m9,3591,264 740.4%   
Current liabilities Rs m4,844689 703.3%   
Net working cap to sales %45.041.2 109.2%  
Current ratio x1.91.8 105.3%  
Inventory Days Days49163 30.3%  
Debtors Days Days391,419 2.8%  
Net fixed assets Rs m2,061911 226.2%   
Share capital Rs m50156 32.1%   
"Free" reserves Rs m5,8111,307 444.8%   
Net worth Rs m5,8611,462 400.8%   
Long term debt Rs m00-   
Total assets Rs m11,4212,175 525.0%  
Interest coverage x213.93.4 6,358.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 136.9%   
Return on assets %8.76.1 142.4%  
Return on equity %16.95.7 299.1%  
Return on capital %23.011.7 196.6%  
Exports to sales %00-   
Imports to sales %37.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m3,747NA-   
Fx inflow Rs m612602 101.6%   
Fx outflow Rs m3,747161 2,331.1%   
Net fx Rs m-3,135441 -710.3%   
CASH FLOW
From Operations Rs m58326 2,254.1%  
From Investments Rs m18179 228.8%  
From Financial Activity Rs m-245-7 3,419.0%  
Net Cashflow Rs m51998 530.6%  

Share Holding

Indian Promoters % 0.0 69.2 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 0.0 -  
FIIs % 2.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 30.8 81.2%  
Shareholders   29,032 9,062 320.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs KILITCH DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs KILITCH DRUGS Share Price Performance

Period ASTRAZENECA PHARMA KILITCH DRUGS S&P BSE HEALTHCARE
1-Day 0.01% -0.09% 1.18%
1-Month -3.61% -3.31% -0.75%
1-Year 59.20% 172.81% 61.82%
3-Year CAGR 20.50% 68.56% 18.16%
5-Year CAGR 22.18% 14.41% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the KILITCH DRUGS share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of KILITCH DRUGS the stake stands at 69.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of KILITCH DRUGS.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

KILITCH DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of KILITCH DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.